Fig. 2
From: Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
Effect of the F11R/JAM-A-derived peptide 4D on cell morphology. The EA.hy926, HMEC-1, and MDA-MB-231 cells were untreated (Control), treated with the control scrambled peptide (Scr), or with the F11R/JAM-A antagonistic peptide (P4D) at a concentration of 500 μM at the time of cell seeding in 6-well plates. Seven days after seeding the microphotographs in brightfield channel were taken using the ZOE Fluorescent Cell Imager (Bio-Rad) in two randomly chosen fields of view of each well